PDCA循环管理模式对卒中患者住院并发症的影响研究

doi:10.3969/j.issn.1673-5765.2023.11.017

摘要/Abstract

摘要： 目的探索PDCA循环管理模式对卒中患者住院期间并发症的影响。
方法连续纳入2021年1月1日—2022年10月31日首都医科大学附属北京天坛医院血管神经病学病区的住院卒中患者作为研究对象。将2021年1月1日—10月31日，即PDCA循环管理模式实施前的住院患者设为对照组；2022年1月1日—10月31日，即实施PDCA循环管理模式后的住院患者设为观察组，进行回顾性分析。收集入组患者的人口学特征、临床特点等信息，比较两组患者住院期间卒中并发症（肺部感染、深静脉血栓、尿路感染）的发生率。
结果本研究共纳入1480例患者，其中观察组患者767例，对照组患者713例。入组患者平均年龄为（71.9±13.6）岁，男性比例为75.3%。观察组患者既往心房颤动病史的比例显著高于对照组（9.9% vs. 5.9%，P=0.004），既往糖尿病病史比例低于对照组（30.0% vs. 34.9%，P=0.043），两组其他基线指标差异无统计学意义。卒中并发症方面，观察组患者住院期间肺部感染（1.3% vs. 3.4%，P=0.008）及深静脉血栓（1.0% vs. 2.4%，P=0.045）的发生率均较对照组低。
结论采用PDCA循环管理模式能够降低卒中患者住院期间肺部感染及深静脉血栓的发生率。

文章导读： 采用PDCA循环管理法能够降低患者住院期间肺部感染及深静脉血栓的发生率，有效提升卒中医疗质量，改善患者预后。

关键词: 卒中; 并发症; PDCA循环管理模式

Abstract: Objective To explore the effect of PDCA circulation management on complications in stroke patients.
Methods Patients with stroke who were hospitalized in the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University from January 1, 2021 to October 31, 2022 were enrolled. The control group consisted of patients who were hospitalized from January 1 to October 31, 2021 before the PDCA circulation management was implemented. The observation group consisted of patients who were under PDCA circulation management from January 1 to October 31, 2022. Demographic characteristics and clinical characteristics of the enrolled patients were recorded, and the incidence of stroke complications (pulmonary infection, deep vein thrombosis, urinary tract infection) during hospitalization was compared between the two groups.
Results 1480 patients were included in this study, including 767 patients in the observation group and 713 patients in the control group. The mean age of enrolled patients was 71.9±13.6, and the male proportion was 75.3%. The observation group had a higher proportion of patients with previous atrial fibrillation (9.9% vs. 5.9%, P=0.004) and a lower proportion of patients with previous diabetes than that in the control group(30.0% vs. 34.9%, P=0.043). There were no significant differences in other baseline indicators between the two groups. In terms of stroke complications, the incidence of pulmonary infection (1.3% vs. 3.4%, P=0.008) and deep vein thrombosis (1.0% vs. 2.4%, P=0.045) during hospitalization in the observation group was lower than that in the control group, and the differences were statistically significant.
Conclusions PDCA circulation management could reduce the incidence of pulmonary infection and deep vein thrombosis in stroke patients during hospitalization.

Key words: Stroke; Complications; PDCA circulation management

吴治瑞, 董可辉, 龚浠平. PDCA循环管理模式对卒中患者住院并发症的影响研究[J]. 中国卒中杂志, 2023, 18(11): 1331-1335.

WU Zhirui, DONG Kehui, GONG Xiping. Effect of PDCA Circulation Management on Complications in Stroke Patients[J]. Chinese Journal of Stroke, 2023, 18(11): 1331-1335.

参考文献

[1] GBD 2016 Neurology Collaborators. Global，regional，and national burden of neurological disorders，1990-2016：a systematic analysis for the global burden of disease study 2016[J]. Lancet Neurol，2019，18（5）：459-480.
[2] WANG W Z，JIANG B，SUN H X，et al. Prevalence，incidence，and mortality of stroke in China：results from a nationwide population-based survey of 480 687 adults[J]. Circulation，2017，135（8）：759-771.
[3] MA Q F，LI R，WANG L J，et al. Temporal trend and attributable risk factors of stroke burden in China，1990-2019：an analysis for the global burden of disease study 2019[J/OL]. Lancet Public Health，2021，6（12）：e897-e906[2023-08-15]. https://doi.org/10.1016/S2468-2667（21）00228-0.
[4] WU S M，WU B，LIU M，et al. Stroke in China：advances and challenges in epidemiology，prevention，and management[J]. Lancet Neurol，2019，18（4）：394-405.
[5] ZHOU M G，WANG H D，ZENG X Y，et al. Mortality，morbidity，and risk factors in China and its provinces，1990-2017：a systematic analysis for the global burden of disease study 2017[J]. Lancet，2019，394（10204）：1145-1158.
[6] 闫允岱，王谦. 脑卒中常见并发症的防治[J]. 中国中医急症，2010，19（7）：1142，1199.
YAN Y D，WANG Q. Prevention and treatment of common complications of stroke[J]. J Emerg Tradit Chin Med，2010，19（7）：1142，1199.
[7] TØNDEL B G，MORELLI V M，HANSEN J B，et al. Risk factors and predictors for venous thromboembolism in people with ischemic stroke：a systematic review[J]. J Thromb Haemost，2022，20（10）：2173-2186.
[8] WANG Y J，LI Z X，GU H Q，et al. China stroke statistics：an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases，China National Clinical Research Center for Neurological Diseases，the Chinese Stroke Association，National Center for Chronic and Non-communicable Disease Control and Prevention，Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations[J]. Stroke Vasc Neurol，2022，7（5）：415-450.
[9] XU C Y，YE H W，CHEN B，et al. Analysis of risk factors and prognosis of post-stroke pulmonary infection in integrated ICU[J]. Eur Rev Med Pharmacol Sci，2021，25（2）：856-865.
[10] SMITH C，ALMALLOUHI E，FENG W. Urinary tract infection after stroke：a narrative review[J/OL]. J Neurol Sci，2019，403：146-152[2023-08-15]. https://doi.org/10.1016/j.jns.2019.06.005.
[11] WESTENDORP W F，DAMES C，NEDERKOORN P J，et al. Immunodepression，infections，and functional outcome in ischemic stroke[J]. Stroke，2022，53（5）：1438-1448.
[12] LIN L P，LIANG Z P，LI Z P，et al. Effect of plan-do-check-active method combined with air pressure wave therapy on the prevention of deep venous thrombosis in critically ill patients in neurosurgery[J]. Ann Palliat Med，2023，12（1）：103-110.
[13] XU Y L，HU Y R，XU J J，et al. Study on the application of tracking methodology and PDCA circulation management in quality control of hospital infection management[J/OL]. Panminerva Med，2021[2023-08-15]. https://doi.org/10.23736/S0031-0808.21.04327-5.
[14] 刘丽，赵晓燕. PDCA护理管理在脑卒中压力性损伤管理中的应用[J]. 中国卫生产业，2021，18（33）：5-8.
LIU L，ZHAO X Y. Application of PDCA nursing management in stroke pressure injury management[J]. China Health Industry，2021，18（33）：5-8.
[15] 黄骁，傅瑜，樊东升. 运用PDCA循环法优化急性缺血性脑卒中患者静脉溶栓院内流程的效果分析[J]. 中国现代医学杂志，2021，31（16）：75-77.
HUANG X，F Y，FAN D S. Application of PDCA cycle to optimize in-hospital process of intravenous thrombolysis in patients with acute ischemic stroke[J]. Chin J Modern Med，2021，31（16）：75-77.
[16] BARTHELS D，DAS H. Current advances in ischemic stroke research and therapies[J/OL]. Biochim Biophys Acta Mol Basis Dis，2020，1866（4）：165260[2023-08-15]. https://doi.org/10.1016/j.bbadis.2018.09.012.
[17] CAMPBELL B C V，DE SILVA D A，MACLEOD M R，et al. Ischaemic stroke[J/OL]. Nat Rev Dis Primers，2019，5（1）：70[2023-08-15]. https://doi.org/10.1038/s41572-019-0118-8.
[18] GUZIK A，BUSHNELL C. Stroke epidemiology and risk factor management[J]. Continuum（Minneap Minn），2017，23（1，Cerebrovascular Disease）：15-39.
[19] WÄSTFELT M，CAO Y，STRÖM J O. Predictors of post-stroke fever and infections：a systematic review and meta-analysis[J/OL]. BMC Neurol，2018，18（1）：49[2023-08-15]. https://doi.org/10.1186/s12883-018-1046-z.
[20] THEOFANIDIS D，GIBBON B. Nursing interventions in stroke care delivery：an evidence-based clinical review[J]. J Vasc Nurs，2016，34（4）：144-151.
[21] BOON G J A M，VAN DAM L F，KLOK F A，et al. Management and treatment of deep vein thrombosis in special populations[J]. Expert Rev Hematol，2018，11（9）：685-695.
[22] BEMBENEK J，KARLINSKI M，KOBAYASHI A，et al. Early stroke-related deep venous thrombosis：risk factors and influence on outcome[J]. J Thromb Thrombolysis，2011，32（1）：96-102.
[23] ANDRÉ C，DE FREITAS G R，FUKUJIMA M M. Prevention of deep venous thrombosis and pulmonary embolism following stroke：a systematic review of published articles[J]. Eur J Neurol，2007，14（1）：21-32.
[24] SI Y X，YUAN H，JI P，et al. The combinative effects of orem self-care theory and PDCA nursing on cognitive function，neurological function and daily living ability in acute stroke[J]. Am J Transl Res，2021，13（9）：10493-10500.
[25] HUANG L，LU C，W PANG M，et al. Effect of PDCA-based nursing intervention on activities of daily living，neurological function and self-management in acute cerebral stroke[J]. Am J Transl Res，2021，13（5）：5315-5321.